SCHEMBL6425518

SCHEMBL6425518

CCOC(=O)c1ccc(Br)c(OCC(=O)CC)c1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
MAPT P10636 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA7 P43166 2/20 0.40
CA9 Q16790 2/20 0.40
CA14 Q9ULX7 2/20 0.40
USP2 O75604 1/20 0.39
ALOX15 P16050 1/20 0.39
ALDH1A1 P00352 4/20 0.38
HSD17B10 Q99714 3/20 0.38
KDM4E B2RXH2 3/20 0.37
RXFP1 Q9HBX9 1/20 0.37
MAOB P27338 1/20 0.36
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6425637 0.87 TSHR (0.44) TSHRMAPTMEN1KMT2ANPSR1
SCHEMBL7559624 0.87 MAPT (0.51) TSHRMAPTMEN1KMT2ANPSR1
SCHEMBL6695927 0.86 MEN1 (0.46) TSHRMAPTMEN1KMT2ANPSR1
SCHEMBL6151662 0.84 HSD17B10 (0.40) TSHRALOX15ALDH1A1HSD17B10KDM4E
SCHEMBL9119101 0.83 TSHR (0.45) TSHRMAPTMEN1KMT2ANPSR1
SCHEMBL5105601 0.82 L3MBTL1 (0.41) TSHRMAPTMEN1KMT2ANPSR1
SCHEMBL6203971 0.82 TSHR (0.45) TSHRMAPTMEN1KMT2AALDH1A1
SCHEMBL8492599 0.81 MAPT (0.52) TSHRMAPTMEN1KMT2ANPSR1
SCHEMBL6425417 0.81 TSHR (0.38) TSHRMAPTMEN1KMT2ANPSR1
SCHEMBL6425420 0.81 TSHR (0.38) TSHRMAPTMEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6930208-B2 3-Keto- or 3- oxime-ether-substituted benzoylcyclohexanediones BAYER CROPSCIENCE GMBH (DE) 2005-08-16 US disclosed
US-20040204320-A1 3-Keto- or 3- oxime-ether-substituted benzoylcyclohexanediones BAYER CROPSCIENCE GMBH (DE) 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204320-A1 3-Keto- or 3- oxime-ether-substituted benzoylcyclohexanediones CBR3, CBR1, CYP2E1 TSHR 1287/4885MAPT 3893/4885MEN1 4503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.